After Hours Summary: SOFI -5.3% falls on weak guidance; VAPO -18.8% as it withdraws FY22 rev guidance; LEVI +1% ticks higher on earningsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: CXM +9.9%, SKIL +6%, RGP +5.4%, LEVI +1%, SLP +0.4%
Companies trading higher in after hours in reaction to news: GENI +7.5% (Sportico details NFL as largest US shareholder in GENI), ADVM +3.1% (receives feedback from the FDA; to proceed with IND amendment process for ADVM-022 in wet AMD), SENS +2.2% (first US patient implanted with Eversense E3 CGM System), RLGT +1.7% (expects to report another record quarter in MarQ), SPRO +0.9% (announces publication in NEJM for its Phase 3 ADAPT-PO clinical trial), AXON +0.6% (acquires Foundry 45), LMT +0.5% (hypersonic-missile delay puts the US further behind Russia and China, according to Bloomberg), COF +0.4% (authorizes repurchase of up to an additional $5 bln of common shares), NETI +0.2% (exec recently purchased 40,000 shares), COST +0.1% (reports adjusted March comps of +12.2%), AHT +0.1% (reports preliminary 1Q22 RevPAR data), FB +0.1% (to launch virtual coins for the metaverse, according to FT)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: VAPO -18.8% (withdraws FY22 rev guidance due to slowdown in COVID hospitalizations; guides Q1 revs below consensus), IRNT -10.4%, SOFI -5.3% (lowers FY22 rev guidance below consensus)
Companies trading lower in after hours in reaction to news: CCCS -10.2% (commences 20 mln share public offering by selling shareholders), VAXX -3.4% (to receive CEPI funding for Phase 3 UB-612 heterologous booster trial), AVB -1.9% (commences 2 mln share public offering), BHR -0.2% (reports preliminary 1Q22 RevPAR data), ASR -0.2% (reports March traffic data), VAL -0.2% (awarded multiple contracts, with associated contract backlog of $181 mln), VLRS -0.1% (reports March traffic data), AMZN -0.1% (SEC is probing how AMZN disclosed its business practices, according to WSJ)